US 7759335
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted A61PA61P1/16A61P3/04
Quick answer
US patent 7759335 (Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes) held by Jenrm Discovery, Inc. expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrm Discovery, Inc.
- Grant date
- Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P1/16, A61P3/04, A61P3/06, A61P3/10